Related Experiment Videos
The reversion of highly tumorigenic cell lines to non-tumorigenic phenotype is associated with c-jun down-expression
Y Lavrovsky1, Y Yefremov, V Lavrovsky
1Rockefeller University, New York, NY 10021.
Abstract:
Using model spontaneously reverting cell lines, c-jun, junB, junD and c-fos oncogene expression was investigated. c-jun, but not junB, junD or c-fos, was overexpressed in highly tumorigenic clones. The reversion of cells to the non-tumorigenic phenotype resulted in a dramatic decrease in c-jun expression. CAT assays revealed that c-jun overexpression in tumorigenic cells was associated with higher transcription activity. No correlation between c-jun oncogene expression and AP-1 transcription factor activity in tumorigenic and non-tumorigenic clones was found.
Insights
Overexpression of the c-jun oncogene correlates with increased tumor formation in cell models. Reducing c-jun expression reversed cells to a non-tumorigenic state, highlighting its role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Expression
Background:
- Jun oncogenes, including c-jun, junB, junD, and c-fos, play roles in cellular processes.
- Altered oncogene expression is linked to tumorigenesis and cancer progression.
Purpose of the Study:
- To investigate the role of c-jun, junB, junD, and c-fos oncogene expression in cell tumorigenicity.
- To determine the relationship between c-jun expression levels and the transcription activity of AP-1.
Main Methods:
- Utilized model spontaneously reverting cell lines to study oncogene expression.
- Assessed oncogene expression (c-jun, junB, junD, c-fos) in tumorigenic and non-tumorigenic clones.
- Employed CAT assays to evaluate transcription activity associated with c-jun.
Main Results:
- c-jun was significantly overexpressed in highly tumorigenic cell clones compared to junB, junD, and c-fos.
- Reversion to a non-tumorigenic phenotype was accompanied by a substantial decrease in c-jun expression.
- Higher transcription activity was observed in tumorigenic cells with c-jun overexpression.
- No correlation was found between c-jun oncogene expression and AP-1 transcription factor activity.
Conclusions:
- c-jun oncogene overexpression is associated with a highly tumorigenic cellular phenotype.
- Modulating c-jun expression impacts cellular tumorigenicity, suggesting its potential as a therapeutic target.
- AP-1 transcription factor activity is not directly correlated with c-jun oncogene expression levels in this model.